263 related articles for article (PubMed ID: 21449664)
1. Advances in iron chelation: an update.
Heli H; Mirtorabi S; Karimian K
Expert Opin Ther Pat; 2011 Jun; 21(6):819-56. PubMed ID: 21449664
[TBL] [Abstract][Full Text] [Related]
2. Design of iron chelators with therapeutic application.
Zhou T; Ma Y; Kong X; Hider RC
Dalton Trans; 2012 Jun; 41(21):6371-89. PubMed ID: 22391807
[TBL] [Abstract][Full Text] [Related]
3. The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia.
Fibach E; Rachmilewitz EA
Ann N Y Acad Sci; 2010 Aug; 1202():10-6. PubMed ID: 20712766
[TBL] [Abstract][Full Text] [Related]
4. Iron chelators may help prevent photoaging.
Kitazawa M; Iwasaki K; Sakamoto K
J Cosmet Dermatol; 2006 Sep; 5(3):210-7. PubMed ID: 17177742
[TBL] [Abstract][Full Text] [Related]
5. Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity.
Chaston TB; Richardson DR
Am J Hematol; 2003 Jul; 73(3):200-10. PubMed ID: 12827659
[TBL] [Abstract][Full Text] [Related]
6. Iron: a new target for pharmacological intervention in neurodegenerative diseases.
Whitnall M; Richardson DR
Semin Pediatr Neurol; 2006 Sep; 13(3):186-97. PubMed ID: 17101458
[TBL] [Abstract][Full Text] [Related]
7. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
8. Synthetic and natural iron chelators: therapeutic potential and clinical use.
Hatcher HC; Singh RN; Torti FM; Torti SV
Future Med Chem; 2009 Dec; 1(9):1643-70. PubMed ID: 21425984
[TBL] [Abstract][Full Text] [Related]
9. The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies.
Kontoghiorghes GJ; Kolnagou A; Skiada A; Petrikkos G
Hemoglobin; 2010 Jun; 34(3):227-39. PubMed ID: 20524813
[TBL] [Abstract][Full Text] [Related]
10. The evolution of iron chelators for the treatment of iron overload disease and cancer.
Kalinowski DS; Richardson DR
Pharmacol Rev; 2005 Dec; 57(4):547-83. PubMed ID: 16382108
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective Potential of Iron Chelators and Prochelators.
Jansová H; Šimůnek T
Curr Med Chem; 2019; 26(2):288-301. PubMed ID: 28933303
[TBL] [Abstract][Full Text] [Related]
12. Iron: effect of overload and deficiency.
Hider RC; Kong X
Met Ions Life Sci; 2013; 13():229-94. PubMed ID: 24470094
[TBL] [Abstract][Full Text] [Related]
13. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
Liu G; Men P; Kenner GH; Miller SC; Bruenger FW
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):599-611. PubMed ID: 15113026
[TBL] [Abstract][Full Text] [Related]
14. The potential application of iron chelators for the treatment of neurodegenerative diseases.
Hider RC; Roy S; Ma YM; Le Kong X; Preston J
Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
[TBL] [Abstract][Full Text] [Related]
15. Oral iron chelators.
Kwiatkowski JL
Hematol Oncol Clin North Am; 2010 Feb; 24(1):229-48. PubMed ID: 20113905
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Macromolecular Iron Chelators.
Bulbake U; Singh A; Domb AJ; Khan W
Curr Med Chem; 2019; 26(2):323-334. PubMed ID: 30182850
[TBL] [Abstract][Full Text] [Related]
17. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
Prus E; Fibach E
Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of iron chelators in diseases associated with iron mismanagement.
Weinberg ED
J Pharm Pharmacol; 2006 May; 58(5):575-84. PubMed ID: 16640825
[TBL] [Abstract][Full Text] [Related]
19. Iron chelation in the treatment of cancer: a new role for deferasirox?
Bedford MR; Ford SJ; Horniblow RD; Iqbal TH; Tselepis C
J Clin Pharmacol; 2013 Sep; 53(9):885-91. PubMed ID: 23740857
[TBL] [Abstract][Full Text] [Related]
20. Iron and iron chelators: a review on potential effects on skin aging.
Pouillot A; Polla A; Polla BS
Curr Aging Sci; 2013 Dec; 6(3):225-31. PubMed ID: 23866012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
